Beltrão
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Researchers evaluate how the new coronavirus rewires human proteins for its own replication, and identify several antiviral drugs ready for clinical trials…
Identifying how potential COVID-19 drugs work
EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells…
Drivers of evolution hidden in plain sight
A rapid, versatile mechanism that modifies proteins is revealed to be crucial for the evolutionary process…
EMBL-EBI hosts the Cambridge New Therapeutics Forum
CamNTF hosts meetings around Cambridge, open to all scientists interested in new therapeutics…
See data in a new light
3D printing, gaming, virtual reality and lenticular posters bring new perspectives to research…
